Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
COLLEGIUM PHARMACEUTICAL, INC (COLL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026"
08/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/07/2023 8-K Other Events  Interactive Data
08/03/2023 8-K Investor presentation, Quarterly results
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Investor presentation, Quarterly results
03/15/2023 144 Form 144 - Report of proposed sale of securities:
03/01/2023 144 Form 144 - Report of proposed sale of securities:
02/23/2023 10-K Annual Report for the period ended December 31, 2022
02/13/2023 8-K Quarterly results
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 6.6% stake in Collegium Pharmaceutical Inc.
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2023 8-K Quarterly results
01/30/2023 SC 13G/A BlackRock Inc. reports a 17.1% stake in COLLEGIUM PHARMACEUTICAL INC
01/04/2023 8-K Quarterly results
12/22/2022 8-K Quarterly results
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
09/12/2022 SC 13G/A JANUS HENDERSON GROUP PLC reports a 5.8% stake in Collegium Pharmaceutical, Inc.
08/11/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/13/2022 8-K/A Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/10/2022 8-K Quarterly results
04/13/2022 8-K Investor presentation
Docs: "Corporate presentation"
04/06/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/06/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy